NO901067L - Fremgangsmaate for fremstilling av tiofener. - Google Patents

Fremgangsmaate for fremstilling av tiofener.

Info

Publication number
NO901067L
NO901067L NO90901067A NO901067A NO901067L NO 901067 L NO901067 L NO 901067L NO 90901067 A NO90901067 A NO 90901067A NO 901067 A NO901067 A NO 901067A NO 901067 L NO901067 L NO 901067L
Authority
NO
Norway
Prior art keywords
tiophenes
procedure
preparation
Prior art date
Application number
NO90901067A
Other languages
English (en)
Norwegian (no)
Other versions
NO901067D0 (no
Inventor
Murdoch Allan Eakin
Michael John Cooper
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of NO901067D0 publication Critical patent/NO901067D0/no
Publication of NO901067L publication Critical patent/NO901067L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO90901067A 1989-03-08 1990-03-07 Fremgangsmaate for fremstilling av tiofener. NO901067L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898905336A GB8905336D0 (en) 1989-03-08 1989-03-08 Chemical compounds

Publications (2)

Publication Number Publication Date
NO901067D0 NO901067D0 (no) 1990-03-07
NO901067L true NO901067L (no) 1990-09-10

Family

ID=10652978

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90901067A NO901067L (no) 1989-03-08 1990-03-07 Fremgangsmaate for fremstilling av tiofener.

Country Status (17)

Country Link
EP (1) EP0386920A3 (fr)
JP (1) JPH02273670A (fr)
KR (1) KR900014354A (fr)
CN (1) CN1046160A (fr)
AU (1) AU5005190A (fr)
CA (1) CA2011036A1 (fr)
DD (1) DD298786A5 (fr)
FI (1) FI901177A0 (fr)
GB (2) GB8905336D0 (fr)
HU (1) HUT53097A (fr)
IL (1) IL93470A0 (fr)
NO (1) NO901067L (fr)
NZ (1) NZ232629A (fr)
PL (2) PL284198A1 (fr)
PT (1) PT93357A (fr)
ZA (1) ZA901552B (fr)
ZW (1) ZW2390A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
ES2171839T3 (es) 1996-09-05 2002-09-16 Lilly Co Eli Analogos de carbazol como agonistas adrenergicos selectivos de beta3.
US5808080A (en) * 1996-09-05 1998-09-15 Eli Lilly And Company Selective β3 adrenergic agonists
CO5011072A1 (es) 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2464952A1 (fr) * 1979-09-13 1981-03-20 Roussel Uclaf Nouveaux derives thienyliques, leur procede de preparation et leur application comme medicaments
CA1262729A (fr) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
GB8519154D0 (en) * 1985-07-30 1985-09-04 Ici Plc Aromatic ethers

Also Published As

Publication number Publication date
IL93470A0 (en) 1990-11-29
ZW2390A1 (en) 1990-11-21
CN1046160A (zh) 1990-10-17
DD298786A5 (de) 1992-03-12
HU901285D0 (en) 1990-05-28
EP0386920A3 (fr) 1991-11-27
PL288672A1 (en) 1991-09-23
PL284198A1 (en) 1991-05-20
PT93357A (pt) 1990-11-07
NO901067D0 (no) 1990-03-07
NZ232629A (en) 1992-08-26
GB8905336D0 (en) 1989-04-19
KR900014354A (ko) 1990-10-23
AU5005190A (en) 1990-09-13
HUT53097A (en) 1990-09-28
GB9003434D0 (en) 1990-04-11
ZA901552B (en) 1990-11-28
CA2011036A1 (fr) 1990-09-08
FI901177A0 (fi) 1990-03-08
EP0386920A2 (fr) 1990-09-12
JPH02273670A (ja) 1990-11-08

Similar Documents

Publication Publication Date Title
NO900830L (no) Fremgangsmaate for fremstilling av piperidinforbindelser.
NO904987L (no) Fremgangsmaate for fremstilling av indolderivater.
NO902003D0 (no) Fremgangsmaate for fremstilling av n-heteroaryl-4-quinolinaminer.
NO885454L (no) Fremgangsmaate for fremstilling av triklormonosilan.
NO901554L (no) Fremgangsmaate for fremstilling av dinatrium-cefodizim.
NO894210L (no) Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.
NO904285L (no) Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner.
NO903431D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO903275L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO895032L (no) Fremgangsmaate for fremstilling av 2-benzotiazoliner.
NO903043L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO890159D0 (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler.
NO903207L (no) Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater.
NO901067D0 (no) Fremgangsmaate for fremstilling av tiofener.
NO903666L (no) Fremgangsmaate for fremstilling av pyrrolokinolinforbindelser.
NO902762D0 (no) Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater.
NO900969L (no) Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin.
NO904060D0 (no) Fremgangsmaate for fremstilling av substituerte dibenzofuraner.
NO904535L (no) Fremgangsmaate for fremstilling av fenoksy-heterocykliske forbindelser.
NO895040D0 (no) Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer.
NO905047L (no) Fremgangsmaate for fremstilling av selenofenderivater.
NO904070L (no) Fremgangsmaate for fremstilling av alkanfenoner.
NO890538D0 (no) Fremgangsmaate for fremstilling av oxadiazolyl-azabicyclo-heptaner.
NO920207L (no) Fremgangsmaate for fremstilling av 6-methyl-oestra-4,6-diener
NO890819D0 (no) Fremgangsmaate for fremstilling av hydroksybenzaldehyder.